An Uncommon Instance of Mycotic Pseudoaneurysm in the Common Femoral Artery Due to Septic Ankle Arthritis: Considerations for Surgical and Endovascular Approaches - Scorecard - MDSpire

An Uncommon Instance of Mycotic Pseudoaneurysm in the Common Femoral Artery Due to Septic Ankle Arthritis: Considerations for Surgical and Endovascular Approaches

  • By

  • Samuelson E. Osifo

  • Brian N. King

  • Andrew H. Smith

  • February 9, 2026

  • 0 min

Share

Clinical Scorecard: An Uncommon Instance of Mycotic Pseudoaneurysm in the Common Femoral Artery Due to Septic Ankle Arthritis: Considerations for Surgical and Endovascular Approaches

At a Glance

CategoryDetail
ConditionMycotic pseudoaneurysm of the common femoral artery secondary to septic ankle arthritis
Key MechanismsInfection via hematogenous seeding from remote musculoskeletal infection leading to arterial wall infection and pseudoaneurysm formation
Target PopulationPatients with vascular infections, particularly those with bacteremia from musculoskeletal sources
Care SettingMultidisciplinary vascular surgery, orthopedic surgery, infectious disease, and endovascular intervention in hospital setting

Key Highlights

  • Mycotic aneurysms are rare (<1% of aneurysms) but carry high morbidity including rupture, sepsis, and limb loss.
  • In situ reconstruction with autologous vein grafts is preferred over extra-anatomic bypass due to better infection resistance and patency.
  • Endovascular techniques can be adjunctive but require careful infection control and preservation of surgical graft integrity.

Guideline-Based Recommendations

Diagnosis

  • Use computed tomographic angiography (CTA) to identify pseudoaneurysm size and extent.
  • Obtain blood cultures and site-specific cultures to identify causative pathogens.
  • Employ imaging (MRI, radiographs) to assess source of infection such as osteomyelitis or septic arthritis.

Management

  • Initiate broad-spectrum intravenous antibiotics targeting common pathogens including MRSA.
  • Perform surgical excision and extensive debridement of infected arterial segments.
  • Use autologous reversed femoral vein grafts for in situ arterial reconstruction.
  • Apply rotational muscle flaps and negative pressure wound therapy for soft tissue coverage and infection control.
  • Coordinate multidisciplinary care including orthopedic debridement of infected joints.
  • Consider staged endovascular revascularization after infection control to address distal occlusions.

Monitoring & Follow-up

  • Monitor inflammatory markers (ESR, CRP) and leukocyte counts to assess infection control.
  • Perform serial imaging to evaluate graft patency and resolution of infection.
  • Assess clinical signs of limb perfusion and wound healing postoperatively.

Risks

  • Risk of graft reinfection if infection control is inadequate.
  • Potential for rupture or limb ischemia if pseudoaneurysm is untreated.
  • Iatrogenic injury during endovascular intervention near fresh surgical anastomoses.

Patient & Prescribing Data

Elderly patients with comorbidities including diabetes, chronic kidney disease, and vascular disease presenting with infected pseudoaneurysms

Targeted intravenous antibiotics (e.g., vancomycin and piperacillin-tazobactam) are essential alongside surgical and endovascular interventions; early multidisciplinary involvement improves outcomes.

Clinical Best Practices

  • Early multidisciplinary collaboration among vascular surgery, orthopedics, and infectious disease teams.
  • Use of autologous vein grafts for arterial reconstruction in infected fields to reduce reinfection risk.
  • Careful planning of endovascular access to avoid disruption of fresh surgical grafts and anastomoses.
  • Employ negative pressure wound therapy and muscle flap coverage to optimize soft tissue healing.
  • Staged approach with initial infection control followed by endovascular revascularization for distal occlusions.

References

Original Source(s)

Related Content